Navigation Links


Dulbeccos in Biological Technology

Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)

...tains luciferin (lyophilized) and luciferase assay buffer. 4. PBS 1X - dulbeccos Phosphate Buffered Saline (PBS). Irvine Scientific, Cat. #9235. Phone: 800-... 1. PBS-BSA solution was prepared by adding 1% bovine serum albumin to dulbeccos PBS 1X. 2. The firefly luciferase stock standard (1 mg/mL) was pre...

Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities

...the LipofectAMINE:DNA complex, and added to cells prewashed with dulbeccos MEM to remove serum and antibiotics. The transfection continued ...ime the LipofectAMINE:DNA complex was replaced with high-glucose dulbeccos MEM containing 5% fetal bovine serum, penicillin and streptomyci...

Rapid hit confirmation and early hERG liability testing using the IonWorks HT system

... Fisher Cat. #SS266-1) Tissue culture flasks: Cells grown in T-75 flasks (Corning Cat. #430641) Cell culture media: dulbeccos Modified Eagle Medium (Gibco, Cat. #11965-092) 10% Fetal Bovine Serum (FBS, Irvine Cat. #3000), 1% Penicillin-Streptomycin ...

The QIAGEN Guide to Animal Cell Culture

...itable medium for each cell type must be determined experimentally. Common basal media include Eagle minimal essential medium (MEM), dulbeccos modified Eagle medium (DMEM), RPMI 1640, and Ham F10. These contain a mixture of amino acids, glucose, salts, vitamins, and other nu...

Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators

... than the control, when cells were treated with 100 ng/ml of EGF, and almost 50-fold higher when cells were challenged with PMA (60 ng/ml). dulbeccos modified Eagles medium (DMEM) and dimethylsulfoxide (DMSO) were used as negative controls. Fig.4 F...

Optimizing Transfection Conditions for Studying Signal Transduction Pathways

...nsfection was kept constant with different amounts of an unrelated plasmid (pBluescript plasmid). After transfecting, cells were maintained in dulbeccos minimal essential medium containing 0.5% fetal bovine serum. The pFR-Luc reporter plasmid, which contains the entire coding sequence of the lucife...
Dulbeccos in Biological Products
Other TagsRelatedRelatedRelatedRushRushDevicesDevicesDevicesDevicesDevicesTypeTypeTypeTypeTypeTypefloatevolveddropdropdropdropdroppopulations
(Date:12/3/2009)... , Leading mental health researchers are warning ...s of climate change will be on mental health, yet ...at the UN climate change conference in Copenhagen ...rom the Institute of Psychiatry (IoP) at King,s Co...y scientists into the potential mental health impa...
(Date:12/3/2009)... 20-year study shows it cut risk factors linked t..., THURSDAY, Dec. 3 (HealthDay News) -- Breast-fe...ficantly lower a woman,s risk of metabolic syndrom...tors -- years later, reports a new study appearing...women who didn,t have pregnancy-related (gestation...
(Date:12/3/2009)... , Cindi Kessock receives... Tulsa, OK (PRWEB) December 2, 2009 -- C...m offering HRMS and ERP applications to businesses...Annual Employee Awards., , ,Each year at their com...evement among their employees. This year, Cindi K...
(Date:12/3/2009)... , Insightra Medical, Inc...announced the launch of its new ventral hernia rep...he standard sublay technique, which completely obv...turing. , (PRWEB) Decembe...based medical device company today announced the l...
(Date:12/3/2009)... , , McALLEN, Texas, Dec. 3 /PRNewswire...SG ), announced today that it has acquired three T...Terrace Rehabilitation & Healthcare Center in ...p; Healthcare in Brownsville; and the 95-bed Veran...he acquisitions were effective December 1, 2009. ,...
Breaking Medicine News(10 mins):Health News:Major impacts of climate change expected on mental health 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3
(Date:12/2/2009)...University Medical Center researchers have figured...glioma may be better able to resist radiation ther...ing pathway in these cancer stem cells, they were ... in a laboratory experiment. , The work builds ... cells resist the effects of radiation much better...
(Date:12/2/2009)...e smokeless tobacco product called moist snuff pl...nnesota to urge the tobacco industry to change man...carcinogens. Their study is published online in AC...y . It reports that this category of tobacco produ...oxic and cancer-causing substances. Called polycyc...
(Date:12/2/2009)...r muscles can twitch, before the thought telling i...te of sortscalled an ion channelmust open in the s...chemical signals that spur the cell to action. New...and Technology (NIST) has allowed scientists to ob... the first time, potentially offering insights for...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Nervy research: Researchers take initial look at ion channels in a model system 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18
Other Contentstelomeretelomeretelomeretelophasetelsontemplatetemplatetemplatetemplatetemplatetemplatetemplatetendonstendonstendonstendonstendontendontendontendontendoncodoncodoncodonterminationterminationterminationterminationterminationterminationterminationterminationtermination